Herbalife: Should You Dare Invest in This Controversial Company Going Into Earnings?

Herbalife (NYSE: HLF  ) , the global supplier of nutritional products, has been in the news quite a bit over the last few years. The headlines have been more negative than positive as of late, however. Here are a few events from April alone:

  • April 11: The F.B.I. begins a criminal investigation into Herbalife's business practices over claims of it being a pyramid scheme.
  • April 14: New York Attorney General Eric Schneiderman begins an investigation into Herbalife over claims of it being a pyramid scheme. 
  • April 17: Illinois Attorney General Lisa Madigan begins an investigation into Herbalife over claims of it being a pyramid scheme that targets minorities. 

There is obviously a theme here, and the company's stock has reacted by falling approximately 30% year-to-date. With all this negativity in the air, the company has announced that earnings results for the first quarter will be released on April 28. Let's take a look at the most recent quarterly earnings, expectations for the upcoming report, and one of its top competitors, Nu Skin (NYSE: NUS  ) , to determine if we should be buying or avoiding an investment right now.

Source: Herbalife

A fruitful fourth quarter
On Feb. 18, Herbalife released its fourth-quarter report to cap off fiscal 2013. The results exceeded analyst expectations; here's a breakdown:

Metric Reported Expected
Earnings Per Share $1.28 $1.25
Revenue $1.27 billion $1.25 billion

Source: Benzinga

Source: Herbalife

Earnings per share increased 28% and revenue increase 19.8% year-over-year, resulting in the best fourth quarter in Herbalife's history. Worldwide volume rose 13% and sales grew in all but one of Herbalife's six regions, led by growth of 121.2% in China and 42.9% in South and Central America. Operating income increased 13.8% to $181.86 million, but the operating margin took a slight hit; it declined 76 basis points to 14.33%.

These strong results and the ample free cash flow generated allowed Herbalife to repurchase roughly $30 million of common stock and maintain its quarterly dividend of $0.30. This showed that the company is still fully dedicated to maximizing shareholder value.

Overall, it was a great quarter for Herbalife. Shares reacted by rallying at the open of the next trading session, before falling about 4% on the day. Shares have continued lower on the news of the multiple investigations, and now sit more than 18% below the level they were at before earnings were released.

Expectations & what to watch for
First-quarter results are due out after the market closes on April 28. Analysts currently expect growth on both the top and bottom lines. Here's an overview:

Metric Expected Year Ago
Earnings Per Share $1.30 $1.27
Revenue $1.23 billion $1.12 billion

Source: Estimize

These expectations call for earnings per share to increase 2.4% and revenue to increase 9.8% year-over-year. This growth is well below what we are used to seeing out of Herbalife, but would still result in the best first quarter in the company's history. Other than the key metrics, there are three updates and statistics that will be important to watch for:

Source: Herbalife

  1. First and foremost, it will be absolutely crucial to watch for comments about the effects, if any, that the ongoing investigations will have on earnings going forward. With the investigations being in the pubic eye, it may prevent new independent distributors from signing up and it may cause slowed ordering from existing distributors and customers. If this is the case, we could see major weakness in the stock.
  2. With the previous idea in mind, it will be very important for Herbalife to provide guidance for the second quarter that is within analyst expectations. Currently, the estimates call for earnings per share of $1.54 and revenue of $1.34 billion; this would represent year-over-year increases of 9.2% and 9.8%, respectively. 
  3. While second-quarter guidance will be important, so will Herbalife's guidance for the full year of fiscal 2014. Watch and make sure the company reaffirms or raises the guidance it provided in the fourth-quarter report, which projected earnings per share in the range of $5.85-$6.05 on revenue growth of 7.5%-9.5% from fiscal 2013. 
If Herbalife can attain analysts' earnings expectations and satisfy the three factors above, and I think it will, it would result in a great quarter. However, unless Herbalife makes incredibly positive comments about the investigations, the company's stock will likely show very little movement to the upside. Federal investigations cast a dark cloud over everything for a public company, even the most bullish of earnings announcements, so I would avoid an investment until the investigations are completed and the public is informed of the findings.

A competitor who faced similar issues

Source: Nu Skin

One of Herbalife's largest competitors, Nu Skin, has faced its fair share of adversity over the last few quarters, but the situation has finally taken a turn for the better. Let me explain.

It all began on Jan. 15 of this year when the People's Daily, a communist newspaper in China, accused Nu Skin of operating as an illegal pyramid scheme. Does this sound familiar? When the story broke, it caused Nu Skin's stock to fall 15.56% in the trading session, but the company responded by saying the accusations were both inaccurate and exaggerated. However, the decline only worsened the following day when Chinese authorities announced that an investigation had been opened.

Although it may have seemed like Nu Skin was doomed to be shut down in China, the investigation turned up very little wrong-doing. Here's a summary of the fines that were handed down on March 24:

  1. Nu Skin must pay $524,000 for products that were not permitted for sale by independent distributors. The products in question were approved for sale in the company's retail locations in China, but not for the direct selling channel.
  2. The company must also pay a $16,000 fine for product claims that lack sufficient data to support them. Nu Skin will either have to obtain support for the claims or the products can no longer be sold in China.
  3. Six members of Nu Skin's sales team will have to pay fines of $241,000 for "unauthorized promotional activities." The company itself will not have to pay any fines for the actions of these six sales representatives, but it has been asked to enhance the education and supervision of its sales team.

Source: Nu Skin

For a company that did over $3 billion in sales during fiscal 2013, fines of $540,000 are pocket change. I believe this was arguably the best possible outcome for Nu Skin and the market agreed, sending its shares soaring over 18% in the trading session that followed. This may be the start of a run back toward its 52-week high, which it still sits more than 35% below.

Herbalife can only hope that the investigations into its business turns out as well as Nu Skin's did, but it is still a situation that investors should steer clear of. Yes, the reward could be great if the investigations turn up little wrongdoing. It could also devastate the company if the opposite were to happen. Due to the risk alone, I would avoid an investment in Herbalife for now and would instead consider Nu Skin the better option because its situations are resolved and it is back to focusing on growing its business.

The Foolish bottom line
Herbalife may be under pressure from U.S. regulators right now, and it is for this reason that it is not a great time to invest in the company's shares. First-quarter results will be announced shortly and analyst estimates seem doable, but I think even blowout numbers would cause little movement in the company's stock due to the pending investigations. After all, G.A.A.P. earnings matter little if your company is found to be an illegal pyramid scheme. Foolish investors should wait for all of the investigations to be completed before considering an investment. If you are looking for an immediate entry into the industry, take a deeper look into Nu Skin.

Boost your 2014 returns with The Motley Fool's top stock
There’s a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it’s one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Read/Post Comments (2) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 28, 2014, at 3:43 PM, earlcarroll wrote:

    meanwhile back at the ranch THE STOCK WAS UP TODAY.....bill stiritz, carl Icahn, George soros and several other billionaires who are long the stock and selling puts have done their own investigation...this group of billionaires have a lot better investigators, lawyers, and analysts than the government could ever hire.. do you think Icahn would have put so many on the hlf board if he had not done a thorough investigation...DUE is what these billionaires do and they do it very well, ackman on the other hand NOT SO MUCH I use j c penny , target. and now hlf as my examples...these billionaires just keep selling puts and the puts just keep expiring worthless.. and once these investigations end and hlf gets a fine and a slap on the wrist the stock goes to 100 bucks a share and all the shorts will be SQUEEEEEZED lie volkswagon was..this is going to make a great movie once it is more thing...only 18 percent of hlf sales are in the united states so WHAT IS THE WORST POSSIBLE OUTCOME?? they lose 18 percent of there sales...IT IS NOT POSSIBLE FOR IT TO GO TO ZERO

  • Report this Comment On May 13, 2014, at 7:52 PM, Hansen wrote:

    Herbalife has recently announced that it will be issuing convertible notes to raise $1 billion, and has plans to use a major part of it to fund its buyback program in fiscal year 2014

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2920390, ~/Articles/ArticleHandler.aspx, 9/2/2015 12:52:55 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Joseph Solitro

A fan of innovation, strong fundamentals, and all things baseball. Follow on Twitter @JoeySolitro. Fool on!

Today's Market

updated 3 hours ago Sponsored by:
DOW 16,058.35 -469.68 -2.84%
S&P 500 1,913.85 -58.33 -2.96%
NASD 4,636.11 -140.40 -2.94%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/1/2015 4:00 PM
HLF $55.22 Down -2.35 -4.08%
Herbalife CAPS Rating: *
NUS $44.72 Down -0.96 -2.10%
Nu Skin Enterprise… CAPS Rating: **